BTX - BioTime EPS of $0.30 May, 09 2019 04:51 PM Brooklyn ImmunoTherapeutics Inc. BioTime (NYSEMKT:BTX): Q1 EPS of $0.30 may not be comparable to consensus of -$0.07.Revenue of $0.9M (+28.6% Y/Y) beats by $0.26M.Press ReleaseMore news on: BioTime, Inc., Earnings news and commentary, Healthcare stocks news, ,